Discover how leading R&D teams use Cypris Q to monitor technology landscapes and identify opportunities faster - Book a demo Executive Summary GLP-1based obesity pharmacotherapy has evolved from single-hormone appetite suppression into a platform competition spanning poly-agonist biology, delivery convenience, and body-composition optimization
While significant muscle growth takes longer, the improved nitrogen retention and protein synthesis create a fuller, more dense appearance to existing muscle tissue
They mimic a natural hormone called glucagon-like peptide-1 (GLP-1 ) , which plays a crucial role in regulating appetite, blood sugar, and digestion
This can be concerning because maintaining lean muscle mass is especially important for people taking GLP-1 medications to support strength, metabolism, and bone health during weight loss (3)
Continuous use increases side effect risk and promotes desensitization